ATHX Message Board Post 10887658 | Athersys Inc.
home / stock / athx / athx message board
reamonpgh
(investorshangout)
Posted on: Jun/06/2022 20:16:06
Source: investorshangout
https://investorshangout.com/post/view?id=6416294
znewcar1: ATHX 24% v14,2M c.3028 f258M H0.329 ML.18 gap@.33-.55
News, Short Squeeze, Breakout and More Instantly...
-
Athersys, Inc. (OTC: ATHX), a regenerative medicine company developing MultiStem ® (invimestrocel) cell therapy for critical care indications, announced financial results for the three and nine months ended September 30, 2023 and provided a business update. Third Quarter 2023 and...
-
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
-
Athersys, Inc. (Nasdaq: ATHX), (“Athersys” or the “Company”) a cell therapy and regenerative medicine company developing MultiStem ® (invimestrocel) for critical care indications, announces it has entered into a warrant exercise inducement offer letter to ra...